Diabetes softens generics blow for Sanofi
October 30, 2012Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff
Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …
Lilly appoints new chief ethics and compliance officer and senior VP
October 30, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly
Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …
Canada latest country to suspend sales of Novartis vaccines
October 30, 2012Manufacturing and Production Canada, Novartis, vaccines
Canada has said it will suspend sales of two flu vaccines made by Novartis – following in the footsteps of …
Shionogi and ViiV strike new HIV deal
October 30, 2012Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV
HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …
Pharmalink AB strengthens senior management
October 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB
Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …
Boehringer to increase production of Respimat inhaler
October 30, 2012Manufacturing and Production Boehringer Ingelheim, Respimat SMI, Soft Mist
Boehringer Ingelheim is investing €85 million in manufacturing capacity for its Respimat Soft Mist Inhaler in the face of growing …
Patheon buys softgel specialist Banner in $255m deal
October 30, 2012Manufacturing and Production Capsugel, Patheon, banner pharmacaps
Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …
Teva’s CML drug approved
October 29, 2012Research and Development, Sales and Marketing FDA, Synribo, Teva
Teva’s new treatment for chronic myeloid leukemia Synribo has been approved by the FDA. Synribo (omacetaxine mepesuccinate) is an injectable …
Almirall welcomes UCB head into Board of directors
October 29, 2012Manufacturing and Production, Research and Development, Sales and Marketing Almirall, Gerhard Mayr
Almirall has approved the appointment of Gerhard Mayr as a new independent member to its Board of directors. He is …
EU countries suspend sales of Novartis flu vaccines
October 29, 2012Manufacturing and Production, Sales and Marketing EU, Novartis, vaccines
Contamination of Novartis flu vaccines with white particles has resulted in regulatory actions from various authorities in the EU, including …
The NHS revolution – one wave at a time
October 26, 2012Sales and Marketing CCGs, NHS, pharma-NHS partnerships
The first group of prospective Clinical Commissioning Groups (CCGs) will have to wait a little longer to hear if they …
Turning business intelligence managers into business performance leaders
October 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, MSI, business leaders, intelligence
Never before have business intelligence people played such a leading role in the marketing planning process. For those who view …
Sharp fall for AstraZeneca
October 26, 2012Sales and Marketing AstraZeneca, Brennan, Q3, Soriot
AstraZeneca saw its third quarter revenue and pre-tax profit both fall 15%, to $6.7 billion and $2 billion, respectively. The …
Astellas announces compliance officer for the Americas
October 26, 2012Manufacturing and Production, Research and Development, Sales and Marketing Astellas, McCauley
Astellas recently named J. Patrick McCauley Jr, a longtime pharmaceutical industry veteran and Astellas employee, to the post of Regional …
Shire poaches new head from Bayer
October 26, 2012Sales and Marketing Angus Russell, Flemming Omskov, Shire
Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …
Contaminated steroids blamed for deadly meningitis outbreak
October 25, 2012Manufacturing and Production FDA, GMP, NECC
As many as 14,000 patients may have been exposed to contaminated steriods that have led to 23 deaths due to …
Lilly censured for rep photo
October 25, 2012Medical Communications, Sales and Marketing ABPI, GP, PMCPA, lilly
Lilly has breached the ABPI’s Code of Practice because one of its representatives insisted on taking pictures of doctors underneath …
AstraZeneca and Ironwood announce $150 million China pact
October 25, 2012Research and Development, Sales and Marketing AstraZeneca, China, IBS, Ironwood
AstraZeneca has signed a deal with Ironwood to co-develop and co-market Ironwood’s irritable bowel syndrome treatment in China. In August …
Perception of pharma online ‘negative’
October 25, 2012Medical Communications, Sales and Marketing Digital Health Coalition, Endo, WEGO Health
Pharma manufacturers must take to social media in a bid to correct misinformation about the industry and their products, according …
Management Forum NSF-DBA Medical Devices Certification Programme
October 24, 2012Research and Development
Management Forum has teamed up with NSF-DBA, experts in medical device professional training, to bring certification programmes aimed at demonstrating …
Latest content
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
